Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)
NCT02298673 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new MS-based biomarker for the early and sensitive diagnosis of Mucolipidosis Disorder type I,II,III or IV from blood (plasma)
Conditions
- Skeletal Abnormalities
- Psychomotor Retardation
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Egypt
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
Biomarkers and Validation of Selected Outcome Measures (CMTBiomarker)
NCT03386266 ·Status: COMPLETED
-
Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease
NCT07049588 ·Status: RECRUITING ·Phase: NA
-
Neurometabolic Profile of Individuals With Primary Mitochondrial Disease
NCT06890520 ·Status: RECRUITING
-
Multi-center Screening for Serum M Protein
NCT06750965 ·Status: NOT_YET_RECRUITING
-
Gut Microbiota in Patients With Moyamoya Disease
NCT04890782 ·Status: UNKNOWN
-
A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
NCT06082284 ·Status: RECRUITING
-
Metabolomic Exploration of Dysregulated Lipid Metabolism in MFN2-related CMT2A (MetaDLM_CMT2A)
NCT04881201 ·Status: COMPLETED ·Phase: NA
-
Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies
NCT04917705 ·Status: RECRUITING ·Phase: NA
-
Longitudinal Biomarkers With Selected Outcome Measures In CMT
NCT06794489 ·Status: RECRUITING
-
Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
NCT02596191 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema
NCT04123457 ·Status: ENROLLING_BY_INVITATION
-
Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
NCT06539832 ·Status: RECRUITING
-
Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank
NCT05454527 ·Status: RECRUITING
-
Research on the Application and Mechanism of New Biological Probes in Biomedicine
NCT04977739 ·Status: COMPLETED
-
MRS to Determine Neuroinflammation and Oxidative Stress in MPS I
NCT03576729 ·Status: COMPLETED
-
Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome
NCT02440373 ·Status: COMPLETED
-
myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies
NCT00213629 ·Status: COMPLETED ·Phase: NA
-
Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
NCT06690593 ·Status: RECRUITING
-
Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications
NCT02663362 ·Status: RECRUITING
-
Development and Validation of a Disability Severity Index for CMT
NCT01455623 ·Status: COMPLETED
-
Transcriptomic Study of Adult Population With Marfan Syndrome
NCT05700175 ·Status: RECRUITING
-
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
NCT06527326 ·Status: RECRUITING ·Phase: NA
-
Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans
NCT05556967 ·Status: COMPLETED ·Phase: PHASE3
-
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
NCT01193075 ·Status: RECRUITING
-
GDF-15 as a Biomarker for Mitochondrial Disease
NCT02745938 ·Status: COMPLETED